The growth of teledermatology: Expanding to reach the underserved

The growth of teledermatology: Expanding to reach the underserved

Journal Pre-proof The growth of teledermatology: expanding to reach the underserved Nadiya Chuchvara, BA, Rachel Patel, BA, Radhika Srivastava, BA, Ca...

1MB Sizes 0 Downloads 16 Views

Journal Pre-proof The growth of teledermatology: expanding to reach the underserved Nadiya Chuchvara, BA, Rachel Patel, BA, Radhika Srivastava, BA, Catherine Reilly, BS, Babar Rao, MD, FAAD PII:

S0190-9622(19)33147-0

DOI:

https://doi.org/10.1016/j.jaad.2019.11.055

Reference:

YMJD 14038

To appear in:

Journal of the American Academy of Dermatology

Received Date: 3 October 2019 Revised Date:

17 November 2019

Accepted Date: 26 November 2019

Please cite this article as: Chuchvara N, Patel R, Srivastava R, Reilly C, Rao B, The growth of teledermatology: expanding to reach the underserved, Journal of the American Academy of Dermatology (2020), doi: https://doi.org/10.1016/j.jaad.2019.11.055. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2019 Published by Elsevier on behalf of the American Academy of Dermatology, Inc.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46

Article Type: Health Policy & Practice Title: The growth of teledermatology: expanding to reach the underserved Authors: Nadiya Chuchvara, BA1; Rachel Patel, BA1; Radhika Srivastava, BA1; Catherine Reilly, BS1; Babar Rao, MD, FAAD1,2 1. Center for Dermatology, Rutgers Robert Wood Johnson Medical School at 1 Worlds Fair Drive, Somerset, NJ 08873. 2. Department of Dermatology, Weill Cornell Medical Center at 1305 York Avenue, New York, NY 10021. All correspondence to: Nadiya Chuchvara, BA Center for Dermatology Rutgers Robert Wood Johnson Medical School 1 Worlds Fair Drive Somerset, NJ 08873 Email: [email protected] Capsule Summary Word Count: 46/50 Abstract Word Count: 165/200 Text Word Count (excluding references, figures, and tables): 2491/2500 Table Count: 2 Figure Count: 3 Reference Count: 54 Keywords: dermatology, teledermatology, telemedicine, telehealth, underserved, rural, live video, store-and-forward, reimbursement, private payer, parity, Medicare, Medicaid, cross-state licensing, Interstate Medical Licensure Compact, IMLC Funding sources: None Conflicts of interest: The authors do not have any conflicts of interest to disclose.

1

47 48

Abstract: The regulation of telemedicine in the United States is evolving, with new legislation

49

expanding reimbursement and cross-state licensing capabilities. As telemedicine grows,

50

communities with limited access to traditional dermatologic care may find a solution in

51

teledermatology. A search of the medical literature and online healthcare law resources

52

published within the past decade was performed to assess the current status of telemedicine

53

availability, health record integration and security, reimbursement policy, and licensure

54

requirements in the United States, with a focus on teledermatology. The majority of states have

55

implemented policies requiring private insurance coverage. Medicaid reimburses some form of

56

telemedicine in all states, but restricts which modalities can be used, and by which specialties.

57

Medicare places the heaviest limitations on telemedicine coverage. Twenty-four states and Guam

58

are members of the Interstate Medical Licensure Compact (IMLC), while 27 states offer

59

alternative cross-state practice options. With the advent of publicly and privately funded

60

programs, volunteer efforts, and mobile applications, teledermatology is more readily available

61

to rural and underserved communities.

62 63 64 65 66 67 68 69

2

70 71

Capsule Summary: •

a deficit of dermatologists.

72 73

Teledermatology is a promising method of delivering specialty care to communities with



This study describes the current state of teledermatology in the United States as it relates

74

to utilization, accessibility, health record integration, security, as well as state-specific

75

reimbursement and licensing legislation.

76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 3

94 95

Introduction: Telemedicine is defined as, “the remote diagnosis and treatment of patients by means of

96

telecommunications technology.”1 The concept originated as early as the 1940s, when radiology

97

images were first sent 24 miles over a telephone line for remote evaluation.2 In subsequent

98

decades, multiple US government-funded initiatives provided telemedicine services to special

99

populations, such as astronauts and residents of isolated reservations.2 The rise of the Internet—

100

along with improving communication speeds, information storage, and encryption—has since

101

paved the way for further expansion. Today, physicians from various specialties have adopted

102

telemedicine into their practice, and dermatologists are no exception.3

103

The term “teledermatology” was coined by two dermatologists, Perednia and Brown, in

104

1995.4 Upon observing the shortage of dermatologists in rural Oregon, they investigated

105

teledermatology as an alternative to traditional care.4 The distribution of dermatologists

106

continues to disproportionately favor urban areas in the US. Between 1995 and 2013, the number

107

of dermatologists per 100,000 residents increased from 3.41 to 4.03 in metropolitan areas and

108

from 2.63 to 3.06 in rural areas.5 Patients from rural communities traveled an average of 2.4

109

miles farther to see a dermatologist than patients from metropolitan areas, with some venturing

110

over 200 miles.6 Additionally, patients from rural areas were more likely to be older and

111

impoverished, further compounding the disparity in access.6 Teledermatology provides a time-

112

effective, cost-conscious solution for patients who would otherwise undertake laborious travel to

113

visit a dermatologist.

114

The benefits of teledermatology implementation are supported by the literature. By

115

practicing tele-triage, which prioritizes in-person clinic visits for patients with conditions

116

associated with greater morbidity or mortality—while using telemedicine for the rest—,

4

117

providers can better manage the delivery of specialty dermatologic care to resource-limited

118

settings.7,8 Pilot studies demonstrated a decrease in time-to-consultation for patients—from

119

months/weeks to days/hours—, expediting treatment as a result.9-15 Some studies showed

120

applicability to pediatric populations, as well.16,17

121

The Center for Connected Health Policy (CCHP) classifies telemedicine into three types:

122

live video, store-and-forward, and remote patient monitoring. Live video telemedicine is

123

synchronous, consisting of a real-time interaction between the healthcare provider and the patient

124

using video-conferencing software.18 The remaining two forms of telemedicine, store-and-

125

forward and remote patient monitoring, do not occur in real-time and are therefore asynchronous.

126

Store-and-forward involves the acquisition and storage of clinical information, which is then

127

forwarded for evaluation.18 Remote patient monitoring allows providers to track patient health

128

data over time for those with chronic diseases.18 Due to its heavy reliance on visual data,

129

teledermatology most often utilizes the store-and-forward modality, particularly with clinical and

130

dermoscopic images.19,20 Second to store-and-forward are live video interactions, and third is a

131

hybrid of the two modalities.20 The location of the patient where the telecommunication is

132

initiated is termed the “originating site”, while the dermatologist is at the “distant site”.

133 134 135

Methods: A review of the medical literature was conducted, using the keywords, “telemedicine,”

136

“telehealth,” and “teledermatology” in PubMed, EMBASE, Cochrane Library, and JAAD

137

databases. Additionally, online healthcare news databases, such as mHealthIntelligence and

138

Health Care Law Today, were searched using the same keywords. Articles were chosen based on

139

relevance to the topic of teledermatology and date published (between 2009 and 2019). We

5

140

searched the references of articles for primary sources and additional publications that did not

141

populate in our initial search. For individual state legislation on Medicaid and private payer

142

reimbursement, information was collected from the CCHP Fall 2019 State Telehealth Laws and

143

Reimbursement Policies report and cross-checked with the eVisit and VisuWell state-by-state

144

telemedicine policy resources. Information on Medicare legislation was collected from the

145

Medicare Learning Network Telehealth Services report. Cross-state licensing legislation was

146

determined by the IMLC, CCHP, eVisit websites.

147 148

Results:

149

Utilization and Accessibility

150

According to the US Department of Health and Human Services (HHS), 60% of all US

151

healthcare institutions, and 40% to 50% of hospitals, incorporated some form of telemedicine in

152

their practice in 2016.21 In the American Medical Association’s 2016 Physician Practice

153

Benchmark Survey, it was found that 15.4% of US physicians—and 15% of dermatologists—

154

work in practices that utilize physician-to-patient telemedicine.3 Of the specialist subgroups,

155

dermatologists were in 11th place, well behind the top three users: radiologists (39.5%),

156

psychiatrists (27.8%), and cardiologists (24.1%).3 Still, the number of US teledermatology

157

programs rose from 37 in 2011, to 102 in 2016.20

158

Efforts have been made to expand the use of telemedicine—particularly to benefit the

159

underserved. In 2016, the US Health Resources and Services Administration (HRSA) announced

160

funding for sustainable telehealth programs as part of a multimillion dollar grant package to

161

increase healthcare access in rural and underserved areas.22 Funded by the HHS and HRSA, 12

6

162

regional and 2 national Telehealth Resource Centers provide resources, education, and technical

163

assistance to support these efforts.23

164

Through both public and private funding, teledermatology has paralleled this national

165

movement. The American Academy of Dermatology (AAD) developed AccessDerm as a

166

philanthropic teledermatology platform in 2016, where volunteer dermatologists provide free

167

store-and-forward consultations to patients at Federally Qualified Health Centers in underserved

168

communities.24 In 2016 alone, 62 facilities of the Veterans Health Administration performed

169

101,507 teledermatology consultations.20 The University of Missouri has offered

170

teledermatology services with the Missouri Telehealth Network for over 20 years, expanding

171

care to rural Missourians as one of the longest-running telemedicine programs in the nation.25,26

172

In a younger pilot program, seven Massachusetts community health centers serving low income

173

populations partnered with remote dermatologists for store-and-forward tele-triage.15

174

While most literature describes a “hub-and-spoke” model, where “spokes” of specialist

175

care are initiated from the “hub” of a general practitioner’s office, direct-to-consumer

176

teledermatology is a growing phenomenon. The development of mobile teledermatology

177

applications allows patients to connect with dermatologists more easily than ever, offering a

178

direct-care platform for remote diagnosis and management of skin conditions. These

179

teledermatology consultations are accessible to the uninsured, with fees ranging from $25-60—

180

comparable to a copay.27 As of 2017, there were 106 teledermatology applications available on

181

Apple, Android, and Windows platforms, triple in number since 2014.27

182 183 184

7

185 186

Electronic Health Record Integration and Security Though convenient for the patient, external direct-to-consumer teledermatology

187

platforms can lead to fragmented care, since records of consultations are rarely sent to the

188

patient’s primary care provider.28 Internal teledermatology programs that merge with a patient’s

189

electronic health record (EHR) ensure continuity of care and proper record-keeping.11 Two

190

health systems have published their experiences on teledermatology compatibility with their

191

existing Epic EHR (Systems Corporation, Verona, WI), the most widely used EHR in the US.11

192

Carter et. al. successfully integrated store-and-forward teledermatology with Epic at Parkland

193

Health and Hospital System in Dallas.11 Similarly, dermatologists at Stanford Health Care

194

demonstrated Epic integration with both consultative and patient-initiated teledermatology.10,14

195

The use of mobile applications for teledermatology may pose security risks related to

196

Health Insurance Portability and Accountability Act (HIPAA) compliance. In an analysis of 29

197

direct-to-consumer applications in 2014 by Peart and Kovarik, only 69% were found to be

198

HIPAA compliant.29 If a healthcare provider is a HIPAA-covered entity, it is their responsibility

199

to use a secure platform with data encryption, login controls, and other features listed in the

200

American Telemedicine Association (ATA) Practice Guidelines.30,31 Commonly used

201

applications were evaluated by Armstrong et. al. in 2010 and Ho et. al. in 2013, but there is a

202

need for newer studies to keep up with the rapidly-changing landscape of application

203

development.32,33

204 205 206 207

Reimbursement: Private Payer, Medicaid, and Medicare One point of regulation for telemedicine is reimbursement.34 Since individual states hold autonomy over laws governing private payer and Medicaid coverage, discrepancies are

8

208

prevalent.18 As of October 2019, 36 states and the District of Columbia have passed parity

209

laws.18,35 Coverage parity laws and payment parity laws require private payer insurances to cover

210

and reimburse telemedicine services, respectively, at the same rate as traditional, in-person

211

services (Figure 1).36

212

Medicaid reimbursement plays an important role in telemedicine expansion for

213

underserved patients. All states and the District of Columbia require coverage for live video

214

services, although Massachusetts only reimburses mental/behavioral healthcare delivered in this

215

way (Figure 2).18,35,37 Only 20 states cover store-and-forward teledermatology services (Figure

216

3).18,35,37 While 23 states and the District of Columbia have restrictions on originating and/or

217

distant sites, patients are explicitly allowed to initiate the interaction from home in 19

218

states.18,35,37 Additionally, Medicaid will reimburse a facility fee for eligible originating sites in

219

34 states.18

220

Medicare regulations are by far the most restrictive. The telehealth service must consist

221

of real-time audiovisual communication, barring coverage for asynchronous telemedicine, except

222

for a store-and-forward demonstration program in Alaska and Hawaii.38,39 The originating site

223

must be in a qualifying health center within a rural Health Professional Shortage Area or a

224

county outside a Metropolitan Statistical Area.39 This excludes a patient’s home as a permissible

225

originating site in all cases save for substance use disorder treatment.39 The HRSA provides an

226

online Medicare Telehealth Payment Eligibility Analyzer tool to determine whether a location

227

qualifies.40

228

In order for a telemedicine service to be reimbursed through Medicare, The Current

229

Procedural Terminology/Healthcare Common Procedure Coding System (CPT/HCPCS) code

230

must be on the list of covered Medicare telemedicine services (Table I).38 Additionally, the

9

231

originating site can bill a facility fee for the telemedicine visit using the code Q3014.39

232

Regardless of insurance type, a provider must bill with the proper modifiers: GT for live video,

233

and GQ for store-and-forward.18,37

234

When insurance coverage persists as a barrier to telemedicine utilization, an up-front fee

235

can be charged directly to the patient—generally ranging from $30-75—, with the caveat that the

236

patient must sign a waiver not to use insurance for their telemedicine visit if the provider is in-

237

network.41 There is evidence to support that patients are willing to pay median values of $25-

238

48.84 out-of-pocket for teledermatology services, especially for the benefit of shorter wait time

239

to consultation.42-44

240 241 242

Licensure In most cases, physicians are legally allowed to practice telemedicine only in the state in

243

which they are licensed, posing a barrier to cross-state telemedicine. The Interstate Medical

244

Licensure Compact (IMLC) offers a solution by expediting the process of licensure for qualified

245

physicians who wish to practice in multiple states.45 According to the IMLC, all physicians who

246

possess a full and unrestricted medical license are eligible to apply for expedited licensure in

247

participating states. Currently, 24 states and Guam are members of the IMLC agreement and 5

248

states and the District of Columbia are in the process of joining.45 As of 2019, IMLC legislation

249

has been introduced in New Jersey and South Carolina.45 Beyond the IMLC, some states have

250

special provisions which allow out-of-state physicians to practice telemedicine without acquiring

251

an additional full medical license (Table II).18,35,45

252 253

10

254 255

Discussion: As with most technologies involving remote interaction, there are some drawbacks to

256

teledermatology. Essential elements of the physical examination, including palpation of the skin

257

and lymph nodes, cannot be performed. Lack of in-person interaction can potentially erode the

258

patient-provider relationship, leading to incomplete histories or imprecise communication. Poor

259

quality videos and images can compromise a diagnosis. A combination of these factors might

260

explain why—despite multiple studies demonstrating adequate diagnostic and management

261

concordance in teledermatology—, one weak point is skin cancer.46,47 Diagnostic accuracy of

262

cutaneous malignancies may improve by incorporating teledermoscopy, in which the referring

263

provider sends dermoscopy images for interpretation.31,48 For high-risk patients who require

264

serial lesion surveillance and prefer the direct-to-consumer model, smartphone-attachment

265

dermatoscopes like the DermLite HÜD (3Gen Inc., San Juan Capistrano, CA) and

266

Molescope/Molescope II (Metaoptima Technology Inc., Vancouver, BC, Canada) can be

267

purchased for $79.95-299.49-51

268

Ultimately, the responsibility and potential liability falls on the teledermatology provider

269

in a direct-care interaction and is shared with the referring provider in a teleconsultation.52 It is

270

prudent for providers to determine coverage of telemedicine under their medical liability

271

insurance policy, including cross-state telemedicine, prior to initiating these services.52 The ATA

272

and AAD provide expert guidelines that facilitate the creation of quality teledermatology

273

programs, both in technical caliber and clinical excellence.31,52

274

Despite expansion of telemedicine and teledermatology, most physicians and

275

dermatologists do not see patients via telehealth. Without a standardized definition of

276

telemedicine, variations can lead to vague interpretations of the law, and consequent legislative

11

277

barriers to wider implementation. In states like Colorado, Michigan, and Minnesota, the private

278

insurer decides what qualifies as telemedicine.18 While the 12 states have mandated payment

279

parity by private insurances—making telemedicine a financially practical alternative for

280

providers—, more states have implemented coverage parity instead, which alone does not

281

guarantee equal reimbursement. Despite the fact that store-and-forward is the most-studied and

282

most-practiced modality of teledermatology—used independently in 72% of programs and in

283

combination with live video in another 35%—, it is met with the steepest reimbursement

284

challenges.20 Medicaid in the majority of states, and Medicare as a whole, strictly define

285

telemedicine as a two-way, real-time interaction between patient and provider, preventing

286

coverage for store-and-forward. Still, many states have progressed their legislation to expand

287

Medicaid reimbursement for telemedicine, and Medicare recently approved new CPT codes for

288

prolonged telehealth interactions. Unfortunately, the restrictive nature of Medicare coverage to

289

specific originating sites and geographical locations overlooks the potential benefits of telehealth

290

to all elderly beneficiaries, who often experience challenges with transportation.

291

Regarding cross-state licensing, the IMLC increases the pool of physicians available to

292

patients in rural communities, which is particularly important for delivery of specialty care. In

293

states like Kansas, the number of dermatology providers ranges from 0-1 to 3-4 per 100,000

294

people in the majority of 3-digit ZIP code regions, limiting the extent to which teledermatology

295

can be delivered from within the state.53 Contrast this to states like Florida and Hawaii, where

296

most regions have from 3-4 to 10-plus dermatology providers per 100,000 people.53 Through

297

cross-state licensing, Kansas residents would gain access to out-of-state dermatologists.

298

However, neither Florida nor Hawaii are currently members of the IMLC.45 To optimize this

299

system, more states with a high proportion of dermatologists must join the compact.

12

300

As new legislation expands reimbursement and eases cross-state practice,

301

teledermatology will become more appealing to the provider. More than ever, teledermatology

302

has shown potential as a beneficial and accessible method of delivering care. The growth of

303

mobile applications makes participation easier than ever. Volunteer efforts and pilot programs

304

have demonstrated that telemedicine services can address the barrier between underserved

305

populations and specialty dermatologic care. Government agencies are subsidizing telemedicine

306

as they did many decades ago, allowing for the development of new programs—from schools, to

307

community hospitals, to academic centers.54 Teledermatology stands as a viable option to

308

provide dermatologic care for individuals who would otherwise go without.

309 310 311

Conclusion: Teledermatology is expanding, as evidenced by increased accessibility and functionality,

312

legislative support of insurance coverage, and expedited cross-state licensing. Private payer

313

reimbursement is growing secondary to parity laws. Medicaid reimburses live video

314

teledermatology in nearly all states, and store-and-forward services in nearly half. Medicare

315

reimbursement is the most restrictive. Dermatologists may practice telemedicine across state

316

lines using special licenses and the IMLC in participating states. With growing availability,

317

teledermatology expands access to specialty dermatologic care.

318 319

Acknowledgements:

320

We would like to thank Trilokraj Tejavsi, MD, Chair of the ATA Teledermatology Special

321

Interest Group, for his insight on teledermatology in the US.

322

13

323

References:

324

1.

Telemedicine. Oxford. Lexico Web site.

325

https://www.lexico.com/en/definition/telemedicine. Published 2019. Accessed August 23,

326

2019.

327

2.

Imaging. 1997;10(3 Suppl 1):28. doi:10.1007/bf03168648.

328 329

3.

4.

Perednia DA, Brown NA. Teledermatology: one application of telemedicine. Bull Med Libr Assoc. 1995;83(1):42-47. https://www.ncbi.nlm.nih.gov/pubmed/7703938.

332 333

Kane CK, Gillis K. The use of telemedicine by physicians: still the exception rather than the rule. Health Aff (Millwood). 2018;37(12):1923-1930. doi:10.1377/hlthaff.2018.05077.

330 331

Field MJ. Telemedicine: a guide to assessing telecommunications in healthcare. J Digit

5.

Feng H, Berk-Krauss J, Feng PW, Stein JA. Comparison of dermatologist density

334

between urban and rural counties in the United States. JAMA Dermatology.

335

2018;154(11):1265-1271. doi:10.1001/jamadermatol.2018.3022.

336

6.

Stitzenberg KB, Thomas NE, Dalton K, et al. Distance to diagnosing provider as a

337

measure of access for patients with melanoma. Arch Dermatol. 2007;143(8):991-998.

338

doi:10.1001/archderm.143.8.991.

339

7.

Leavitt ER, Kessler S, Pun S, et al. Teledermatology as a tool to improve access to care

340

for medically underserved populations: A retrospective descriptive study. J Am Acad

341

Dermatol. 2016;75(6):1259-1261. doi:10.1016/j.jaad.2016.07.043.

342

8.

Chansky PB, Simpson CL, Lipoff JB. Implementation of a dermatology teletriage system

343

to improve access in an underserved clinic: A retrospective study. J Am Acad Dermatol.

344

2017;77(5):975-977. doi:10.1016/j.jaad.2017.06.025.

14

345

9.

Nelson CA, Takeshita J, Wanat KA, et al. Impact of store-and-forward (SAF)

346

teledermatology on outpatient dermatologic care: A prospective study in an underserved

347

urban primary care setting. J Am Acad Dermatol. 2016;74(3):484-490 e481.

348

doi:10.1016/j.jaad.2015.09.058.

349

10.

Pathipati AS, Ko JM. Implementation and evaluation of Stanford Health Care direct-care

350

teledermatology program. SAGE Open Med. 2016;4:2050312116659089.

351

doi:10.1177/2050312116659089.

352

11.

Carter ZA, Goldman S, Anderson K, et al. Creation of an internal teledermatology store-

353

and-forward system in an existing electronic health record: a pilot study in a safety-net

354

public health and hospital system. JAMA Dermatol. 2017;153(7):644-650.

355

doi:10.1001/jamadermatol.2017.0204.

356

12.

Jariwala N, Lipoff J. Evaluation of teledermatology implementation with insurance

357

reimbursement in outpatient primary care practices. Journal of the American Academy of

358

Dermatology. 2017;76(6):AB130.

359

13.

Karon A. Teletriage cut dermatology wait times ninefold for patients at a free clinic.

360

MDedge Dermatology. Dermatology News Web site.

361

https://www.mdedge.com/dermatology/article/138985/practice-management/teletriage-

362

cut-dermatology-wait-times-ninefold. Published 2017. Accessed August 24, 2019.

363

14.

Kim GE, Afanasiev OK, O'Dell C, Sharp C, Ko JM. Implementation and evaluation of

364

Stanford Health Care store-and-forward teledermatology consultation workflow built

365

within an existing electronic health record system. J Telemed Telecare.

366

2018:1357633X18799805. doi:10.1177/1357633X18799805.

15

367

15.

Paradise RK, Bettano C, McGuire T. A Teledermatology Initiative to Increase Access for

368

Community Health Center Patients. The New England Journal of Medicine Catalyst.

369

https://catalyst.nejm.org/teledermatology-access-community-health/. Published January

370

3, 2019. Accessed November 13, 2019.

371

16.

Chen TS, Goldyne ME, Mathes EF, Frieden IJ, Gilliam AE. Pediatric teledermatology:

372

observations based on 429 consults. J Am Acad Dermatol. 2010;62(1):61-66.

373

doi:10.1016/j.jaad.2009.05.039.

374

17.

Heffner VA, Lyon VB, Brousseau DC, Holland KE, Yen K. Store-and-forward

375

teledermatology versus in-person visits: a comparison in pediatric teledermatology clinic.

376

J Am Acad Dermatol. 2009;60(6):956-961. doi:10.1016/j.jaad.2008.11.026.

377

18.

Connected Health Policy; Fall 2019.

378 379

State Telehealth Laws & Reimbursement Policies. Public Health Insitute / Center for

19.

Armstrong AW, Wu J, Kovarik CL, et al. State of teledermatology programs in the

380

United States. J Am Acad Dermatol. 2012;67(5):939-944.

381

doi:10.1016/j.jaad.2012.02.019.

382

20.

Yim KM, Florek AG, Oh DH, McKoy K, Armstrong AW. Teledermatology in the United

383

States: an update in a dynamic era. Telemed J E Health. 2018;24(9):691-697.

384

doi:10.1089/tmj.2017.0253.

385

21.

Policy, Office of the Assistant Secretary for Planning and Evaluation; 2016.

386 387

Report to Congress: E-health and Telemedicine. Washington, DC: Office of Health

22.

Wicklund E. HRSA grants target telehealth for veterans, schools, chronic care. mHealth

388

Intelligence Web site. https://mhealthintelligence.com/news/hrsa-grants-target-telehealth-

389

for-veterans-schools-chronic-care. Published 2016. Accessed September 13, 2019.

16

390

23.

About our consortium. National Consortium of Telehealth Resource Centers Web site.

391

https://www.telehealthresourcecenter.org/about-us/. Published 2019. Accessed November

392

13, 2019.

393

24.

AccessDerm. American Academy of Dermatology Web site.

394

https://www.aad.org/members/volunteer/accessderm-teledermatology-program. Accessed

395

August 27, 2019.

396

25.

2007;104(2):139-143. https://www.ncbi.nlm.nih.gov/pubmed/17536443.

397 398

Edison KE, Dyer JA. Teledermatology in Missouri and beyond. Mo Med.

26.

Missouri Telehealth Network. University of Missouri School of Medicine Web site.

399

https://medicine.missouri.edu/offices-programs/missouri-telehealth-network. Accessed

400

November 13, 2019.

401

27.

Flaten HK, St Claire C, Schlager E, Dunnick CA, Dellavalle RP. Growth of mobile

402

applications in dermatology - 2017 update. Dermatol Online J. 2018;24(2).

403

doi:13030/qt3hs7n9z6.

404

28.

Resneck JS, Jr., Abrouk M, Steuer M, et al. Choice, transparency, coordination, and

405

quality among direct-to-consumer telemedicine websites and apps treating skin disease.

406

JAMA Dermatol. 2016;152(7):768-775. doi:10.1001/jamadermatol.2016.1774.

407

29.

2015;72(5):907-909. doi:10.1016/j.jaad.2015.01.019.

408 409

Peart JM, Kovarik C. Direct-to-patient teledermatology practices. J Am Acad Dermatol.

30.

Luxton DD, Kayl RA, Mishkind MC. mHealth data security: the need for HIPAA-

410

compliant standardization. Telemed J E Health. 2012;18(4):284-288.

411

doi:10.1089/tmj.2011.0180.

17

412

31.

Telemed J E Health. 2016;22(12):981-990. doi:10.1089/tmj.2016.0137.

413 414

McKoy K, Antoniotti NM, Armstrong A, et al. Practice guidelines for teledermatology.

32.

Armstrong AW, Sanders C, Farbstein AD, et al. Evaluation and comparison of store-and-

415

forward teledermatology applications. Telemed J E Health. 2010;16(4):424-438.

416

doi:10.1089=tmj.2009.0133.

417

33.

Ho B, Lee M, Armstrong AW. Evaluation criteria for mobile teledermatology

418

applications and comparison of major mobile teledermatology applications. Telemed J E

419

Health. 2013;19(9):678-682. doi:10.1089/tmj.2012.0234.

420

34.

Giambrone D, Rao BK, Esfahani A, Rao S. Obstacles hindering the mainstream practice

421

of teledermatopathology. J Am Acad Dermatol. 2014;71(4):772-780.

422

doi:10.1016/j.jaad.2014.04.043.

423

35.

policy/. Published 2019. Accessed November 11, 2019.

424 425

State telemedicine laws, simplified. eVisit Web site. https://evisit.com/state-telemedicine-

36.

Telemedicine private payer issues. eVisit Web site.

426

https://evisit.com/resources/telemedicine-private-payers-issues/. Published 2018.

427

Accessed August 26, 2019.

428

37.

reimbursement/map/. Published 2019. Accessed November 11, 2019.

429 430

Reimbursement by state. VisuWell Web site. https://visuwell.io/telemedicine-

38.

Lacktman NM. Medicare proposes (and rejects) new telehealth services for 2019. Foley

431

Web site. https://www.foley.com/en/insights/publications/2018/08/medicare-proposes-

432

and-rejects-new-telehealth-servi. Published 2018. Accessed August 26, 2019.

433 434

39.

Telehealth Services. Medicare Learning Network / Centers for Medicare and Medicaid Services; 2019.

18

435

40.

Administration; 2019. https://data.hrsa.gov/tools/medicare/telehealth.

436 437

Medicare Telehealth Payment Eligibility Analyzer. Health Resources & Services

41.

Telemedicine reimbursement guide. eVisit Web site.

438

https://evisit.com/resources/telemedicine-reimbursement-guide/. Published 2018.

439

Accessed September 4, 2019.

440

42.

Raghu TS, Yiannias J, Sharma N, Markus AL. Willingness to pay for teledermoscopy

441

services at a university health center. J Patient Exp. 2018;5(3):212-218.

442

doi:10.1177/2374373517748657.

443

43.

Qureshi AA, Brandling-Bennett HA, Wittenberg E, Chen SC, Sober AJ, Kvedar JC.

444

Willingness-to-pay stated preferences for telemedicine versus in-person visits in patients

445

with a history of psoriasis or melanoma. Telemed J E Health. 2006;12(6):639-643.

446

doi:10.1089/tmj.2006.12.639.

447

44.

Mori WS, Houston N, Moreau JF, et al. Personal burden of isotretinoin therapy and

448

willingness to pay for electronic follow-up visits. JAMA Dermatol. 2016;152(3):338-340.

449

doi:10.1001/jamadermatol.2015.4763.

450

45.

August 26, 2019.

451 452

The IMLC. Interstate Medical Licensure Compact Web site. https://imlcc.org/. Accessed

46.

Warshaw EM, Hillman YJ, Greer NL, et al. Teledermatology for diagnosis and

453

management of skin conditions: a systematic review. J Am Acad Dermatol.

454

2011;64(4):759-772. doi:10.1016/j.jaad.2010.08.026.

455

47.

Finnane A, Dallest K, Janda M, Soyer HP. Teledermatology for the diagnosis and

456

management of skin cancer: a systematic review. JAMA Dermatol. 2017;153(3):319-327.

457

doi:10.1001/jamadermatol.2016.4361.

19

458

48.

2018;102:102-105.

459 460

49.

50.

Dermlite HÜD. 3Gen Web site. https://dermlite.com/products/dermlite-hud. Accessed November 14, 2019.

463 464

Chao E, Meenan CK, Ferris LK. Smartphone-based applications for skin monitoring and melanoma detection. Dermatol Clin. 2017;35:551-557. doi:10.1016/j.det.2017.06.014.

461 462

Bleicher B, Levine A, Markowitz O. Going digital with dermoscopy. Cutis.

51.

Molescope. Molescope by MetaOptima Web site. https://www.molescope.com/product/. Accessed November 14, 2019.

465 466

52.

Position Statement on Teledermatology. American Academy of Dermatology;2016.

467

53.

Glazer AM, Rigel DS. Analysis of trends in geographic distribution of US dermatology

468

workforce density. JAMA Dermatol. 2017;153(5):472-473.

469

doi:10.1001/jamadermatol.2016.6032.

470

54.

Case studies of how hospitals and health systems are using telehealth to expand access

471

and improve care in their communities. American Hospital Association Web site.

472

https://www.aha.org/bibliographylink-page/2017-12-11-use-telehealth-hospitals-and-

473

health-systems-members-action. Accessed August 26, 2019.

474 475 476 477 478 479 480

20

481

Figure Legends:

482

Figure 1. Private payer parity laws. Map of the United States colored according to the status of

483

individual state private payer telemedicine parity laws, with a focus on teledermatology.18,35,37

484

_______________________________________

485

Current through October 2019. Created with mapchart.net.

486

* No coverage parity until January 1, 2021, but requirement for telehealth coverage in

487

dermatology and other conditions/settings

488

† Effective January 1, 2021. Does not apply to Medi-Cal Managed Care.

489

‡ Effective January 1, 2020

490

§ Unless the health provider and payer contractually agree to a lower reimbursement rate

491

| Payment must be at least 75% of traditional services

492

¶ Coverage parity for live video, but not store-and-forward

493 494

Figure 2. Medicaid live video coverage. Map of the United States colored according to the

495

status of individual state Medicaid live video coverage, with a focus on teledermatology.18,35,37

496

_______________________________________

497

Current through October 2019. Created with mapchart.net.

498

* Professional relationship must exist between the patient and the distant site provider

499

† If deemed by the commissioner as appropriate, cost effective, and likely to expand access

500

‡ When services are ongoing, the patient should receive a traditional clinical evaluation at least

501

once per year; the distant site provider should coordinate with the primary care physician

502

§ Mental/behavioral health only

503

| Some restrictions apply (beneficiary cannot travel, imminent health risk)

21

504

¶ Must be at an eligible site, in a rural area with a health professional shortage (same as

505

Medicare)

506

** Distant site must be of a sufficient distance from originating site; prior approval required in

507

some cases

508

†† Only for initial and follow-up inpatient telehealth consultation

509

‡‡ Only by TN Managed Care

510 511

Figure 3. Medicaid store-and-forward coverage. Map of the United States colored according

512

to the status of individual state Medicaid store-and-forward coverage, with a focus on

513

teledermatology.18,35,37

514

_______________________________________

515

Current through October 2019. Created with mapchart.net.

516

* Teledentistry only

517

† Only in the case of provider-to-provider communication (electronic consults)

518

‡ Teledermatology only

519

§ Teleradiology only

520

| Effective January 1, 2020

521

¶ Teledermatology, teleophthalmology, and teleradiology only

522

** Patient must be notified of the right to interactive communication with the distant site

523

provider, who must respond within 30 days of the patient’s request

524

†† Not explicitly included, but may be covered under the definition of telemedicine

525

‡‡ Only by TN Managed Care

526

§§ Outpatient teledermatology, teleradiology, and diabetic retinopathy screening only

22

527

Table I. Covered Medicare telemedicine services (and their CPT/HCPCS codes) of relevance to

528

teledermatology39 Service Telehealth consultations, emergency department or initial inpatient Follow-up inpatient telehealth consultations furnished to beneficiaries in hospitals or SNFs Office or other outpatient visits Prolonged service in the office or other outpatient setting requiring direct patient contact beyond the usual service Prolonged service in the inpatient or observation setting requiring unit/floor time beyond the usual service

CPT/HCPCS Code G0425–G0427 G0406–G0408 99201–99215 99354-99355*

99356-99357*

529 530

_______________________________________

531

* New codes for 2019

532 533 534 535 536 537 538 539 540 541 542

23

543

Table II. Summary of cross-state licensing options in different states and territories, as of

544

October 201918,35,45 Cross-State Licensing Type

States/Territories

IMLC member issuing licenses only (non-SPL)

AL, AZ, CO, IA, ID, IL, KS, MD, ME, MI, MS, MT, ND, NE, NH, NV, SD, TN, UT, WA, WI, WV, WY, and Guam MN

IMLC implementation in process

GA, KY, OK, PA, VT, and District of Columbia

IMLC legislation introduced License to practice across state lines may be granted for fully licensed out-of-state providers License to practice across state lines for fully licensed providers practicing in adjoining states, as long as similar privileges are extended to their own physicians Special purpose license for licensed out-of-state providers Telemedicine license

NJ, SC

Telemedicine certificate Consultation services as requested by in-state provider only Physician-to-physician consultation Infrequent consultation

OHj

IMLC member serving as state of principal licensure (SPL) and issuing licenses

CT, INa, MNb, NDc, NM, ORd, SD, UTe

MDf, PAg

AL, NV LA, OKh, TNh, TXi MEb, MS HI, NH, OK, VA AZk, AR, KYl, MOl, RIm, TX

545 546

_______________________________________

547

a. As long as the licensed out-of-state provider and their employer/contractor file for certification

548

of compliance with the courts of IN

549

b. Must register with the state board and agree not to open an office, meet patients, or receive

550

calls in the state

551

c. Per the state medical board’s discretion

552

d. Must establish a patient-physician relationship, and cannot write prescriptions based on online

553

consult only

24

554

e. Only if services are rendered as a public service and for noncommercial purpose

555

f. Cannot open an office in the state

556

g. Based on availability of medical care in the area involved

557

h. Osteopathic board only

558

i. Must have passed the Texas Medical Jurisprudence Examination

559

j. Must also possess a special activity certificate, which can be converted to a license by written

560

request

561

k. Physician-to-physician only

562

l. If their service was requested by an in-state licensed physician with an established relationship

563

with the patient

564

m. For no more than 7 days unless extended with written permission from the director

565 566 567 568 569 570 571 572 573 574 575 576

25